Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Wheeler

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Technology in Cancer Research & Treatment|January 19, 2006
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancerMichael T Tetzlaff, Bin S Teh, Terry L Timme, et al.
The Journal of Molecular Diagnostics : JMD|December 26, 2012
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomyDimo Dietrich, Oliver Hasinger, Lionel L Bañez, et al.
Cancer Research|June 16, 2022
Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune MicroenvironmentHee-Jin Jang, Hyun-Sung Lee, Wendong Yu, et al.
The Journal of Clinical Investigation|June 9, 2007
Improved prediction of prostate cancer recurrence through systems pathologyCarlos Cordon-Cardo, Angeliki Kotsianti, David A Verbel, et al.
The American Journal of Surgical Pathology|May 28, 2020
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic CarcinomaGeert J L H van Leenders, Theodorus H van der Kwast, David J Grignon, et al.
The American Journal of Surgical Pathology|August 19, 2008
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimensAndrew J Evans, Pauline C Henry, Theodorus H Van der Kwast, et al.
Virchows Archiv : an International Journal of Pathology|October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologistRodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Pathology|December 5, 2014
Active surveillance for prostate cancer: the role of the pathologistBrett Delahunt, Elizabeth Hammond, Lars Egevad, et al.
Archives of Pathology & Laboratory Medicine|June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Archives of Pathology & Laboratory Medicine|August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer FoundationMahul B Amin, Daniel W Lin, John L Gore, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Technology in Cancer Research & Treatment|January 19, 2006
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancerMichael T Tetzlaff, Bin S Teh, Terry L Timme, et al.
The Journal of Molecular Diagnostics : JMD|December 26, 2012
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomyDimo Dietrich, Oliver Hasinger, Lionel L Bañez, et al.
Cancer Research|June 16, 2022
Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune MicroenvironmentHee-Jin Jang, Hyun-Sung Lee, Wendong Yu, et al.
The Journal of Clinical Investigation|June 9, 2007
Improved prediction of prostate cancer recurrence through systems pathologyCarlos Cordon-Cardo, Angeliki Kotsianti, David A Verbel, et al.
The American Journal of Surgical Pathology|May 28, 2020
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic CarcinomaGeert J L H van Leenders, Theodorus H van der Kwast, David J Grignon, et al.
The American Journal of Surgical Pathology|August 19, 2008
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimensAndrew J Evans, Pauline C Henry, Theodorus H Van der Kwast, et al.
Virchows Archiv : an International Journal of Pathology|October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologistRodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Pathology|December 5, 2014
Active surveillance for prostate cancer: the role of the pathologistBrett Delahunt, Elizabeth Hammond, Lars Egevad, et al.
Archives of Pathology & Laboratory Medicine|June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Archives of Pathology & Laboratory Medicine|August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer FoundationMahul B Amin, Daniel W Lin, John L Gore, et al.
Pageof 15